Related Experiment Video
Updated: Jun 17, 2026

10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Potential surrogate endpoints in cancer research--some considerations and examples
1Cancer Research UK Centre for EMS, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Pharmaceutical Statistics
|December 24, 2009
Summary
This survey introduces surrogate endpoints in cancer research and clinical trials. Surrogate endpoints are not universal but depend on treatment mechanisms, with validity measures and examples provided.
Area of Science:
- Oncology
- Clinical Trials
- Biostatistics
Background:
- Surrogate endpoints are crucial in cancer research, particularly for accelerating clinical trials.
- Distinguishing surrogate endpoints from biomarkers is essential for accurate interpretation of trial results.
- The validity and applicability of surrogate endpoints are context-dependent, varying with treatment mechanisms.
Purpose of the Study:
- To provide an introductory survey of surrogate endpoint utilization in cancer research.
- To clarify the definition and characteristics of surrogate endpoints versus biomarkers.
- To discuss the validity, application, and preference of surrogate endpoints in clinical trials.
Main Methods:
- Literature review and conceptual analysis of surrogate endpoints in oncology.
- Comparison of surrogate endpoints and biomarkers with illustrative examples.
- Discussion of validity measures and specific use cases for surrogate endpoints.
Main Results:
- Surrogate endpoints are defined and differentiated from biomarkers.
- The mechanism of treatment dictates the validity of a surrogate endpoint for a specific indication.
- Examples of potential cancer surrogates and biomarkers are presented, alongside criteria for their evaluation.
Conclusions:
- Surrogate endpoints offer potential advantages in clinical trials when appropriately validated and applied.
- Understanding the context-specific nature of surrogate endpoints is vital for reliable cancer research.
- Further exploration of surrogate endpoint literature is recommended for researchers in the field.
Related Concept Videos
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
